As of 2026-10-05, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (15.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.92 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -325.7%.
The range of the Relative Valuation is (13.71) - (21.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 19.8x | 12.4x |
| Forward P/E multiples | 10.8x - 17.1x | 12.8x |
| Fair Price | (13.71) - (21.22) | (15.62) |
| Upside | -298.2% - -406.6% | -325.7% |
| Date | P/E |
| 2026-10-02 | -5.57 |
| 2026-10-01 | -5.70 |
| 2026-09-30 | -5.88 |
| 2026-09-29 | -5.93 |
| 2026-09-28 | -5.92 |
| 2026-09-25 | -5.88 |
| 2026-09-24 | -5.70 |
| 2026-09-23 | -5.62 |
| 2026-09-22 | -6.25 |
| 2026-09-21 | -6.00 |
| 2026-09-18 | -6.02 |
| 2026-09-17 | -6.24 |
| 2026-09-16 | -6.19 |
| 2026-09-15 | -6.57 |
| 2026-09-14 | -6.99 |
| 2026-09-11 | -6.73 |
| 2026-09-10 | -6.74 |
| 2026-09-09 | -6.98 |
| 2026-09-08 | -7.59 |
| 2026-09-04 | -7.65 |
| 2026-09-03 | -7.29 |
| 2026-09-02 | -7.45 |
| 2026-09-01 | -7.56 |
| 2026-08-31 | -7.70 |
| 2026-08-28 | -7.39 |
| 2026-08-27 | -7.20 |
| 2026-08-26 | -7.06 |
| 2026-08-25 | -7.08 |
| 2026-08-24 | -6.97 |
| 2026-08-21 | -7.14 |
| 2026-08-20 | -6.92 |
| 2026-08-19 | -7.50 |
| 2026-08-18 | -7.45 |
| 2026-08-17 | -7.47 |
| 2026-08-14 | -7.71 |
| 2026-08-13 | -7.39 |
| 2026-08-12 | -7.38 |
| 2026-08-11 | -6.85 |
| 2026-08-10 | -6.90 |
| 2026-08-07 | -6.88 |
| 2026-08-06 | -6.75 |
| 2026-08-05 | -6.63 |
| 2026-08-04 | -6.80 |
| 2026-08-03 | -7.23 |
| 2026-07-31 | -7.04 |
| 2026-07-30 | -7.27 |
| 2026-07-29 | -9.37 |
| 2026-07-28 | -9.39 |
| 2026-07-27 | -9.62 |
| 2026-07-24 | -9.21 |